LavaMAX-II

Retatrutide
5 vials x 5 mg

  • Reduces appetite

  • Supports weight loss

  • Helps regulate blood sugar

  • Activates GIP, GLP‑1, and glucagon receptors

LavaMAX-II (Retatrutide) is an investigational oxyntomodulin-based synthetic peptide that functions as a triple agonist targeting the GLP-1, GIP, and glucagon (GCGR) receptors. The insertion of glucagon receptor agonism alongside the two incretin pathways creates a profoundly distinct metabolic state; while GLP-1 and GIP optimize insulin sensitivity and limit food intake, the activation of the glucagon receptor stimulates hepatic lipid turnover, induces direct thermogenesis, and amplifies daily resting energy expenditure.

95%

POPULARITY

Weight-Loss Effect
Nausea During Use
Side-Effect Discontinuation
Do you want to check your product ? Click Here

See Other Products